English
简体中文
Total: £ 56.28
2026-04-13 | Pages: 119 | Tables: 112
The global Medical Spa Management Software market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Medical spa software, or medspa software, is tailored to help medical spas manage the...
2026-04-13 | Pages: 107 | Tables: 101
The global Optogenetic Retinal Gene Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Optogenetic Retinal Gene Therapy is projected to incre...
2026-04-13 | Pages: 102 | Tables: 103
The global Optogenetic Gene Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Optogenetic Gene Therapy is projected to increase from US$ mil...
2026-04-13 | Pages: 107 | Tables: 103
The global Multiomics market was valued at US$ 3136 million in 2025 and is anticipated to reach US$ 6774 million by 2032, at a CAGR of 11.8% from 2026 to 2032.Multiomics is a new approach where the data sets of different omic groups are combined duri...
2026-04-13 | Pages: 150 | Tables: 153
The global ADME DMPK Studies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Drug metabolism and pharmacokinetics (DMPK) studies are a type of preclinical study that is used to...
2026-04-13 | Pages: 153 | Tables: 141
The global Preclinical DMPK Studies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Drug metabolism and pharmacokinetics (DMPK) studies are a type of preclinical study that is ...
2026-04-13 | Pages: 107 | Tables: 105
The global Accelerator Mass Spectrometry (AMS) Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Accelerator Mass Spectrometry (AMS) service is a specialized analytical t...
2026-04-13 | Pages: 112 | Tables: 119
The global Therapeutic Critical Care market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Therapeutic Critical Care is projected to increase from US$ m...
2026-04-13 | Pages: 112 | Tables: 111
The global Organ Preservation for Transplantation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Organ preservation for transplantation involves the process of maintaining org...
2026-04-13 | Pages: 115 | Tables: 115
The global Naturopathy Therapies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Naturopathy Therapies is projected to increase from US$ million i...
2026-04-13 | Pages: 115 | Tables: 115
The global Endometrial Receptivity Testing Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Endometrial receptivity testing service refers to a diagnostic service offere...
2026-04-13 | Pages: 101 | Tables: 108
The global Research Antibodies and Reagents market was valued at US$ 16990 million in 2025 and is anticipated to reach US$ 26190 million by 2032, at a CAGR of 6.5% from 2026 to 2032.Research Antibodies and Reagents refer to a wide range of specialize...
2026-04-13 | Pages: 123 | Tables: 128
The global Hearing Aids Devices market was valued at US$ 11960 million in 2025 and is anticipated to reach US$ 19080 million by 2032, at a CAGR of 7.0% from 2026 to 2032.Hearing aid devices are electronic instruments designed to improve hearing in in...
2026-04-10 | Pages: 103 | Tables: 108
The global Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Mitogen-Activated Prote...
2026-04-10 | Pages: 152 | Tables: 147
The global Decentralized Clinical Trial Solution market was valued at US$ 8611 million in 2025 and is anticipated to reach US$ 17480 million by 2032, at a CAGR of 10.8% from 2026 to 2032.A Decentralized Clinical Trial (DCT) solution refers to a metho...
